Abstract:Objective: To explore the relationship between bitter taste and bitter flavor（efficacy）, their characteristics were analyzed at the target and pharmacodynamic points.Methods: Compounds with bitter receptor activity were obtained by high-throughput screening models of the human bitter taste receptors（h TAS2Rs）, which were used to analyze bitter taste. The efficacy of anti-asthma medications was used as an example to research bitter flavor（efficacy）. The pharmacological effects of bitter taste and bitter flavor（efficacy） were classified according to the functional modules. The coverage for the same targets or pharmacological effects in the overall protein interaction network（PIN）of bitter taste and bitter flavor（efficacy） was analyzed to reveal their relationship. The effect of the compound polydatin with anti-asthma activation on h TAS2R14 was studied to verify the reliability of the aforementioned idea.Results: A total of 121 Chinese materia medica（CMM） compounds that activate h TAS2R10, h TAS2R14,and h TAS2R49 were obtained. The analysis results indicated that 108 same targets for bitter taste and bitter flavor（efficacy） were obtained, accounting for 13.9% in the PIN of bitter taste and 72.5% in the PIN of bitter flavor（efficacy）. The pharmacological effects shared by bitter taste and bitter flavor（efficacy）accounted for 79% of the PIN of bitter taste and 81% of the PIN of bitter flavor（efficacy）. The activating effect of the anti-asthma compound polydatin on h TAS2R14 was dose-dependent with EC50of 4.3 μM.Conclusion: In this study, the relationship between bitter taste and bitter flavor（efficacy） has been demonstrated from the target and pharmacodynamic points, which are based on h TAS2Rs and antiasthma effect. Bitter taste and bitter flavor（efficacy） exhibited a high correlation. This study provides a theoretical and scientific basis for the hypothesis that “the property theory of CMM is the clinical pharmacodynamics of CMM.”

Bitter taste TAS2R14 activation by intracellular tastants and cholesterol

Unlocking TAS2R14 activation through intricate multi-ligand binding networks

Structural basis for strychnine activation of human bitter taste receptor TAS2R46

Intracellular binding pocket revealed in the human bitter taste receptor TAS2R14

Structure-function relationships of the human bitter taste receptor hTAS2R1: insights from molecular modeling studies.

Biosensor recording of extracellular potentials in the taste epithelium for bitter detection

Coarse-grained/molecular mechanics of the TAS2R38 bitter taste receptor: experimentally-validated detailed structural prediction of agonist binding

A bitter-taste receptor activated in a surprising way

Exploring TAS2R46 Biomechanics through Molecular Dynamics and Network Analysis

Insight into the Interaction of Humulus lupulus L. Specialized Metabolites and Gastrointestinal Bitter Taste Receptors: In Vitro Study in STC-1 Cells and Molecular Docking

Bitter taste receptors as sensors of gut luminal contents

The Hidden One: What We Know About Bitter Taste Receptor 39

The human bitter taste receptor TAS2R10 is tailored to accommodate numerous diverse ligands

BitterX: a tool for understanding bitter taste in humans

Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction

Molecular-level understanding of the hTAS2R1 receptor-bitter tasting tetra-peptide binding: a structural biology study based on computational approaches

Discovery of the Relationship Between Bitter Taste and Bitter Flavor (efficacy) Based on Htas2rs

Bitter Peptides Activate Htas2rs, the Human Bitter Receptors.

Identification of ligands for two human bitter T2R receptors

β2-Adrenergic Receptors Chaperone Trapped Bitter Taste Receptor 14 to the Cell Surface as a Heterodimer and Exert Unidirectional Desensitization of Taste Receptor Function

[Advances in bitterness receptors T2Rs in different diseases]